InVivoMab anti-mouse CD86 (B7-2)

Catalog number: BE0025_100mg
Brand: Bio X Cell
Packing: 100 mg
Other sizes: Other sizes available
Price: € 2715.00
Expected delivery time: 7 days
Quantity:

Product specifications for - InVivoMab anti-mouse CD86 (B7-2)

Promotion: 
Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: Flow Cytometry; Neutralisation/Blocking
Species: Mouse
Host: Rat
Clonality: Monoclonal
Isotype: IgG2a Kappa
Properties: 
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: GL-1
Related products: 
Related products: Recommended Isotype Control(s): InVivoMab rat IgG2a isotype control (BE0089)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: GL-1; BE0025; CD86; LAB72; CD28LG2; B70; B7.2; B7-2; T-lymphocyte activation antigen CD86; FUN-1; CTLA-4 counter-receptor B7.2; CD86 antigen (CD28 antigen ligand 2, B7-2 antigen); BU63; B-lymphocyte activation antigen B7-2; CD86 molecule; BioXCell
Marshall D, Sinclair C, Tung S, Seddon B. Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cells. J Immunol. 2014;193(11):5525-33. Read more
Moser EK, Hufford MM, Braciale TJ. Late engagement of CD86 after influenza virus clearance promotes recovery in a FoxP3+ regulatory T cell dependent manner. PLoS Pathog. 2014;10(8):e1004315. Read more
Srivastava S, Koch MA, Pepper M, Campbell DJ. Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection. J Exp Med. 2014;211(5):961-74. Read more
Arjunaraja S, Paoletti LC, Snapper CM. Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo. J Immunol. 2012;188(11):5238-46. Read more
Kastenmuller W, Gasteiger G, Subramanian N, et al. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol. 2011;187(6):3186-97. Read more